Processa Pharmaceuticals, Inc. Noncash or Part Noncash Acquisition, Inventory Acquired
Processa Pharmaceuticals, Inc. (PCSA) reported Noncash or Part Noncash Acquisition, Inventory Acquired of $49.20 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionInventoryAcquired1 · last filed 2014-11-13
- Processa Pharmaceuticals, Inc. noncash or part noncash acquisition, inventory acquired for the quarter ending 2014-03-31 was $0.00.
- Processa Pharmaceuticals, Inc. noncash or part noncash acquisition, inventory acquired for the quarter ending 2013-12-31 was $0.00.
- Processa Pharmaceuticals, Inc. noncash or part noncash acquisition, inventory acquired for fiscal 2013 was $83.51K.
| Period end | Noncash or Part Noncash Acquisition, Inventory Acquired 3 month | Noncash or Part Noncash Acquisition, Inventory Acquired 6 month | Noncash or Part Noncash Acquisition, Inventory Acquired 9 month | Noncash or Part Noncash Acquisition, Inventory Acquired 12 month | Noncash or Part Noncash Acquisition, Inventory Acquired 33 month | Noncash or Part Noncash Acquisition, Inventory Acquired 36 month |
|---|---|---|---|---|---|---|
| 2014-09-30 | $49.20K 10-Q · filed 2014-11-13 | |||||
| 2014-03-31 | $0.00 derived: 10-Q 36 month − 10-K 33 month · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $83.51K 10-Q · filed 2014-05-14 | |||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $83.51K 10-K · filed 2014-03-27 | $83.51K 10-K · filed 2014-03-27 | |||
| 2013-09-30 | $83.51K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |